Physician profile
Willard Thompson
NPI 1265421309
$883.08
in general payments reported to CMS, 2019-2025
17 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $185 · 2021: $191 · 2022: $151 · 2023: $51.92 · 2024: $27.82 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $207.67 | 2020-2024 | N/A |
| Zimmer Biomet Holdings, INC. | $147.03 | 2019-2021 | |
| Medtronic, INC. | $113.08 | 2025 | Strata |
| Integra Lifesciences Corporation | $97.29 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $49.72 | 2019 | |
| Aesculap, INC. | $46.48 | 2020-2021 | |
| Novocure INC. | $45.54 | 2019-2022 | |
| Orthofix Medical, INC. | $23.49 | 2020 | |
| Ethicon US, LLC | $22.69 | 2019 | |
| Radius Health, INC. | $19.24 | 2021 | |
| Misonix INC | $18.91 | 2019 | |
| Abbott Laboratories | $18.61 | 2020 | |
| Medtronic USA, INC. | $17.11 | 2019 | |
| Globus Medical, INC. | $15.65 | 2023 | Direct Look |
| Boston Scientific Corporation | $14.88 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $14.53 | 2022 | |
| Kls-Martin L.P. | $11.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willard Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.